S66 Dec 25 Half Year Report and Financial Statements
Filed with ASX · · 22 pages · English
Appendix 4D half year report Directors' report Financial statements Directors' declaration Auditor's independence declaration Independent auditor's review report 3 5 7 19 20 21 APPENDIX 4D HALF YEAR REPORT Under ASX Listing Rule 4.2A For the half year ended 31 December 2025 1. Company details Name of entity: STAR COMBO PHARMA LTD AND CONTROLLED ENTIIES Current period: 1 July 2025 to 31 December 20
Story so far
Earlier from Star Combo Pharma
- S66 FYE June 2025 Results Announcement
- S66 Preliminary Final Report
- S66 Insurance Claim Settlement
- S66 Dec 2024 Half Year Report & Financial Statements
- S66 2024 Results Announcement
Later from Star Combo Pharma
All Star Combo Pharma news releasesFollow Star Combo Pharma into a list and get an email when it puts out news.
Follow Star Combo Pharma